The effects of iron complementary on hemoglobin level and mood
- Conditions
- Anemia.Iron deficiency anaemia
- Registration Number
- IRCT201210137618N4
- Lead Sponsor
- Deputy of Research, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 225
Students living in dormitories of Tabriz university of medical sciences, Not using vitamin and iron complementary in the last 3 month, Not using oral or injection steroidal hormones, Not using IUD, Not existence of a hepatic, infectious or parasitic diseases in the time of study, Not existence of hematologic disorders such as thalassemia or hemophilia, any contraindication iron complementary, Not existence psychological disorders, Not existence systemic disorders which can affect menstrual bleeding such as diabetes, thyroid disorders, hyperadrenalism,… , participants with signs and symptoms of anemia which investigator finds in clinical examination( assessing color of mucosa, nails, conjunctive), participants with hemoglobin below 12g/dl.
Exclusion criteria: Not being interested to continue (leaving study), diagnosis of other types of anemia during the study, diagnosis of systemic, infectious, parasitic or hepatic disorders during study.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin level. Timepoint: Once before the intervention and second time 4 months after beginning the intervention. Method of measurement: Based on result laboratory by Cell counter device model H1.;Mood. Timepoint: Once before the intervention and second time 4 months after beginning the intervention. Method of measurement: Based on POMS SF questionnaire.
- Secondary Outcome Measures
Name Time Method Menstrual bleeding level. Timepoint: Once before the intervention and second time 4 months after beginning the intervention. Method of measurement: Based on Higham questionnaire.